Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

A molecular basis of kinetoplastids SL trans-splicing

Project description

Deciphering gene expression in parasites

Kinetoplastids are unicellular eukaryotic parasites that cause diseases like sleeping sickness, Chagas disease, and leishmaniasis. They exhibit a unique gene expression pattern producing long RNA chains from multiple genes which are subsequently processed into individual mRNAs. The ERC-funded TranSplice project aims to shed light on this process which is known as SL trans-splicing. The research team will employ techniques such as cryo-electron microscopy and genome editing to delineate the mechanism of SL trans-splicing. Apart from fundamental knowledge, project findings will uncover new drug targets and pave the way for new therapies against kinetoplastid-related diseases.

Objective

Kinetoplastids are unicellular eukaryotic parasites responsible for severe human pathologies, such as sleeping sickness, Chagas disease and leishmaniasis. Kinetoplastids have diverged early during evolution and harbor many intriguing cellular and molecular peculiarities. Among these is their remarkably streamlined nuclear genome characterized by a high gene density and significantly divergent and specialized gene expression systems. A main example of such divergence is the polycistronic transcription of all their genes producing long messenger RNA precursors (pre-mRNAs) containing tens to hundreds of coding sequences. These pre-mRNAs are dissected into monocistronic mRNAs by SL trans-splicing, a process during which a spliced leader (SL) RNA is intermolecularly fused to the 5’end of all mRNAs by the trans-spliceosome. Although this machinery is essential for gene expression, the lack of structural information and the high divergence of its RNA and protein elements have hindered a mechanistic understanding of how kinetoplastids employ SL trans-splicing to generate their entire mRNA transcriptome. Here, we will use innovative approaches to provide the structural and mechanistic basis of SL trans-splicing in kinetoplastids by using cutting-edge structural biology techniques and state-of-the-art genetic and in silico tools. By combining genome editing, purification of endogenous trans-splicing machineries, high-resolution cryo-electron microscopy, AI-based interactome approaches, and novel in vivo assays, we will reveal the mechanism of SL snRNP biogenesis, the molecular basis for SL snRNP intermolecular recognition and activation by the trans-spliceosome, and the central mechanism of trans-splicing orchestrated by the highly divergent kinetoplastids trans-spliceosome. The outcome of this research will transform our understanding of RNA trans-splicing in eukaryotes and will pave the way for developing new drugs that specifically target this unique and essential pathway.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-STG

See all projects funded under this call

Host institution

UNIVERSITE DE LIEGE
Net EU contribution
€ 1 765 625,00
Address
PLACE DU 20 AOUT 7
4000 LIEGE
Belgium
Region
Région de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest Région de Bruxelles-Capitale/ Brussels Hoofdstedelijk Gewest Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 765 625,00

Beneficiaries (1)